Lista de obras - Paul Knöbl - Dominio Público Uruguay

A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5).

artículo científico publicado en 2004

A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A

scientific article published on 30 September 2018

Acquired hemophilia A: Updated review of evidence and treatment guidance.

artículo científico publicado en 2017

Closed suctioning system reduces cross-contamination between bronchial system and gastric juices

artículo científico publicado en 2004

Comparison of enoxaparin and unfractionated heparin in endovascular interventions for the treatment of peripheral arterial occlusive disease: a randomized controlled trial

artículo científico publicado en 2011

Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data

scientific article published on 08 November 2018

Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients

artículo científico publicado en 2020

Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review

artículo científico publicado en 2016

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

artículo científico publicado en 2012

Efficacy and tolerability of non-invasive ventilation delivered via a newly developed helmet in immunosuppressed patients with acute respiratory failure ⬇️

artículo científico publicado el 15 de septiembre de 2003

Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus

scientific article published on 01 May 1995

Evaluation of in vivo antineoplastic effects of rapamycin in patients with chemotherapy-refractory AML.

artículo científico publicado en 2009

Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura

scientific article published on 07 October 2019

Expert statements on the standard of care in critically ill adult patients with atypical haemolytic uraemic syndrome

artículo científico publicado en 2017

Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry

artículo científico publicado en 2002

High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience.

artículo científico publicado en 2005

Immune-mediated disorders causing bleeding or thrombosis in lymphoproliferative diseases

artículo científico publicado en 2014

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

artículo científico publicado en 2012

In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemia

artículo científico publicado en 2016

Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2016

Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma.

artículo científico publicado en 2012

Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura

scientific article published on 24 February 2012

Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years.

artículo científico publicado en 2017

Is It HIT?

artículo científico publicado en 2017

Is ruxolitinib a potentially useful drug in hematological malignancies with RAS pathway hyperactivation?

artículo científico publicado en 2016

Is the determination of anti‐beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome? ⬇️

artículo científico publicado el 1 de noviembre de 2003

Is there an association between hemostatic abnormalities and the outcome of acute lung injury?

artículo científico publicado en 2007

Karyotype plus NPM1 mutation status defines a group of elderly patients with AML (≥60 years) who benefit from intensive post-induction consolidation therapy

artículo científico publicado en 2016

Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors ⬇️

artículo científico publicado el 1 de abril de 1998

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

artículo científico publicado en 2012

Myocardial involvement in a patient with Burkitt's lymphoma mimicking hypertrophic cardiomyopathy.

artículo científico publicado en 2003

Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher age.

artículo científico publicado en 2009

Postoperative paraneoplastic factor VIII auto-antibodies in patients with solid tumours.

artículo científico publicado en 2011

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

artículo científico publicado en 2012

Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A

scientific article published on 01 December 2018

Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

artículo científico publicado en 2015

Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications

artículo científico publicado en 2008

Summary report of the First International Conference on inhibitors in haemophilia A.

artículo científico publicado en 2016

Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis.

artículo científico publicado en 2005

The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical research

scientific article published on 18 July 2019

Thrombotic thrombocytopenic purpura

artículo científico publicado en 2018

Treatment concepts for elderly patients with acute myeloid leukemia.

artículo científico publicado en 2003

Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumab

artículo científico publicado en 2020

Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin)

artículo científico publicado en 2006

Lista de obras de Paul Knöbl

A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5).

A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A

Acquired hemophilia A: Updated review of evidence and treatment guidance.

Closed suctioning system reduces cross-contamination between bronchial system and gastric juices

Comparison of enoxaparin and unfractionated heparin in endovascular interventions for the treatment of peripheral arterial occlusive disease: a randomized controlled trial

Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data

Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients

Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Efficacy and tolerability of non-invasive ventilation delivered via a newly developed helmet in immunosuppressed patients with acute respiratory failure ⬇️

Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus

Evaluation of in vivo antineoplastic effects of rapamycin in patients with chemotherapy-refractory AML.

Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura

Expert statements on the standard of care in critically ill adult patients with atypical haemolytic uraemic syndrome

Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry

High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience.

Immune-mediated disorders causing bleeding or thrombosis in lymphoproliferative diseases

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemia

Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma

Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma.

Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura

Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years.

Is It HIT?

Is ruxolitinib a potentially useful drug in hematological malignancies with RAS pathway hyperactivation?

Is the determination of anti‐beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome? ⬇️

Is there an association between hemostatic abnormalities and the outcome of acute lung injury?

Karyotype plus NPM1 mutation status defines a group of elderly patients with AML (≥60 years) who benefit from intensive post-induction consolidation therapy

Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors ⬇️

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

Myocardial involvement in a patient with Burkitt's lymphoma mimicking hypertrophic cardiomyopathy.

Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher age.

Postoperative paraneoplastic factor VIII auto-antibodies in patients with solid tumours.

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A

Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications

Summary report of the First International Conference on inhibitors in haemophilia A.

Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis.

The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical research

Thrombotic thrombocytopenic purpura

Treatment concepts for elderly patients with acute myeloid leukemia.

Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumab

Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin)